Abstract Background/Objectives: Patients with life-limiting conditions (LLCs) often suffer from restlessness, spasticity, pain, and seizures. Dronabinol (DRB) may have a…
Abstract Supplementary Information: The online version contains supplementary material available at 10.1007/s40122-024-00643-0. Article type: Review Article Keywords: Cannabinoids, Cannabidiol, Tetrahydrocannabinol,…
Abstract Background: Multiple sclerosis (MS) is an inflammatory and degenerative disease of the central nervous system. More than 90,000 Canadians…
Abstract Aim: This prospective, multicenter, open-label, noninterventional 12-week study investigated the effectiveness and tolerability of add-on nabiximols oromucosal spray (Sativex®)…
Abstract Disease or acquired damage to the central nervous system frequently causes disabling spasticity and central neuropathic pain (NP), both…
Abstract Background: Treatment of spasticity poses a major challenge in amyotrophic lateral sclerosis (ALS) patient management. Delta-9-tetrahydrocannabinol (THC):cannabidiol (CBD) oromucosal…
Abstract Introduction: Stroke is the most disabling neurological disorder and often causes spasticity. Transmucosal cannabinoids (tetrahydrocannabinol and cannabidiol (THC:CBD), Sativex)…